

Prof. Dr. med. Sylvie Lorenzen, PhD
gastrointestinal oncology (stomach/esophagus, colorectal and pancreatic)
gastrointestinal oncology (stomach/esophagus, colorectal and pancreatic)
Overview
Country, City
Germany, Munich
Health facility
University Hospital Rechts der Isar Munich
Medical unit
Interdisciplinary chemotherapy centre
About the doctor
Gallery





Prof. Dr. Sylvie Lorenzen, 33rd German Cancer Congress 2018: Gastrointestinal carcinomas
Resume
CV (Curriculum Vitae)
Education
- Studied Medicine at the Technical University of Munich
- Board Certification in Internal Medicine and Medical Oncology
Experience
- Senior Physician at the Department of Internal Medicine III, Klinikum rechts der Isar, Technical University of Munich (TUM)
- Principal Investigator or Sub-Investigator of multiple studies in the field
Awards & Memberships
- Chair of the Gastric Cancer Task Force of the Arbeitsgemeinschaft Internistische Onkologie (AIO; German Cancer Society)
- Member of the Educational Steering Committee of the European Society for Medical Oncology (ESMO) and the Bavarian Ethics Commission
- Investigator of the German Consortium for Translational Research (DKTK)
- Spokesperson and Coordinator of the German Gastric- and Esophageal Cancer Guidelines (S3-Leitlinien)
- First-author of the German Onkopedia Guidelines
- Coauthor of the ESMO Gastroesophageal Cancer Guidelines
- Speaker for the BZKF Gastroesophageal Working Group
- Scientific advisor/reviewer for a number of journals including Annals of Oncology, Annals of Surgical Oncology, Oncology, European Journal of Nuclear Medicine and Expert Opinion on Emerging Drugs
- Review Editor for Frontiers in Oncology
- Since 2020 Editor-in-Chief of the Journal Oncology Research and Treatment
Languages
English
German
Publications
Association of a bundle intervention to address fluid shortages with intraoperative fluid use, total fluid balance, and postoperative outcomes.
March, 2025
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.
3 February, 2025
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.
February, 2025
Location
Ismaninger Str., 22, 81675 Munich, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Sylvie Lorenzen, PhD?
The primary specialization of the doctor is gastrointestinal oncology (stomach/esophagus, colorectal and pancreatic).
What is the rating of the doctor?
Prof. Dr. med. Sylvie Lorenzen, PhD is rated as 9.50 by AiroMedical.
Get individual treatment plan.
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

Prof. Dr. med. Sylvie Lorenzen, PhD
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Sylvie Lorenzen, PhD